Drugs / MELANOMA-ASSOCIATED ANTIGEN 3
MELANOMA-ASSOCIATED ANTIGEN 3
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00003792 | Apr 1999 → Oct 2006 | cutaneous melanoma | Baylor Health Care System | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00002952 | Jan 1997 → Aug 2002 | cutaneous melanoma | University of Chicago | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT01307618 | Feb 2011 → Jan 2015 | melanoma | National Cancer Institute (NCI) | Terminated | No outcome recorded |
| Phase 2 | NCT00254397 | Nov 2005 → Oct 2012 | melanoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT00085189 | May 2004 → Sep 2007 | iris melanoma, medium/large size posterior uveal melanoma, mucosal melanoma, ocular melanoma with extraocular extension +1 | University of Southern California | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00960752 Comparator | May 2010 → Jul 2020 | melanoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MELANOMA-ASSOCIATED ANTIGEN 3 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095361 ↗ |
| Known as | MAGE-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00960752 ↗ |
| Known as | MAGE-3 Peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00254397 ↗ |
| Known as | MAGE-3.1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003792 ↗ |
| Known as | recombinant MAGE-3.1 antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002952 ↗ |
| Modality | Protein / enzyme biologic | “recombinant MAGE-3.1 antigen” NCT00003792 ↗ |
| Route | Subcutaneous | “Given SC or ID” NCT01307618 ↗ |